NEUROSENSE THERAPEUTICS LTD C/W - stock earnings
NRSNW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 784000 USD | ? USD |
| 2023Q2 | -5.2 million USD | ? USD |
| 2023Q1 | -3.8 million USD | ? USD |
| 2022Q4 | -3.0 million USD | ? USD |
| 2022Q3 | -2.7 million USD | ? USD |
| 2022Q2 | -3.5 million USD | ? USD |
| 2022Q1 | -101000 USD | ? USD |
| 2021Q4 | -101000 USD | ? USD |
| 2021Q3 | -888000 USD | ? USD |
| 2021Q2 | -928000 USD | ? USD |
| 2021Q1 | -2.1 million USD | ? USD |
NRSNW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.5 million USD | ? USD |
| 2022 | -11.2 million USD | ? USD |
| 2021 | -2.5 million USD | ? USD |
| 2020 | -2.8 million USD | ? USD |
| 2019 | -1.2 million USD | ? USD |
NRSNW
Price: $0.23
52 week price:
Earnings Per Share: -0.94 USD
P/E Ratio: -0.23
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3227
Market Capitalization: 21.9 million